Pro/con debate: octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin?
- PMID: 16834764
- PMCID: PMC1750992
- DOI: 10.1186/cc4958
Pro/con debate: octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin?
Abstract
Whether it is the primary reason for admission or a complication of critical illness, upper gastrointestinal bleeding is commonly encountered in the intensive care unit. In this setting, in the absence of endoscopy, intensivists generally provide supportive care (transfusion of blood products) and acid suppression (such as proton pump inhibitors). More recently, octreotide (a somatostatin analogue) has been used in such patients. However, its precise role in patients with upper gastrointestinal bleeding is not necessarily clear and the drug is associated with significant costs. In this issue of Critical Care, two expert teams debate the merits of using octreotide in non-variceal upper gastrointestinal bleeding.
Similar articles
-
Drug therapy for non-variceal upper gastrointestinal bleeding. Assessment of options.Digestion. 1999;60 Suppl 3:39-49. doi: 10.1159/000051488. Digestion. 1999. PMID: 10567788 Review.
-
Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage.Hepatology. 2014 Sep;60(3):954-63. doi: 10.1002/hep.27006. Epub 2014 Jul 25. Hepatology. 2014. PMID: 24415445 Clinical Trial.
-
Somatostatin in the treatment of non-variceal upper gastrointestinal bleeding.Dig Dis. 1998 Jul-Aug;16(4):214-24. doi: 10.1159/000016869. Dig Dis. 1998. PMID: 9732181 Review.
-
Octreotide Added to a Proton Pump Inhibitor Versus a Proton Pump Inhibitor Alone in Nonvariceal Upper-Gastrointestinal Bleeds.Ann Pharmacother. 2019 Aug;53(8):794-800. doi: 10.1177/1060028019833696. Epub 2019 Feb 25. Ann Pharmacother. 2019. PMID: 30803243
-
Somatostatin or octreotide in acute variceal bleeding.Digestion. 1999;60 Suppl 2:31-41. doi: 10.1159/000051478. Digestion. 1999. PMID: 10207229 Review.
Cited by
-
Role of octreotide in small bowel bleeding.World J Clin Cases. 2022 Sep 16;10(26):9192-9206. doi: 10.12998/wjcc.v10.i26.9192. World J Clin Cases. 2022. PMID: 36159407 Free PMC article. Review.
-
Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation.Br J Cancer. 2007 May 7;96(9):1343-7. doi: 10.1038/sj.bjc.6603734. Epub 2007 Apr 17. Br J Cancer. 2007. PMID: 17437022 Free PMC article. Clinical Trial.
References
-
- Ludwig D, Schadel S, Bruning A, Schiefer B, Stange EF. 48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study. Dig Dis Sci. 2000;45:1019–1027. doi: 10.1023/A:1005553914878. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical